Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes

作者：Jindra Peter T; Conway Susan E; Ricklefs Stacy M; Porcella Stephen F; Anzick Sarah L; Haagenson Mike; Wang Tao; Spellman Stephen; Milford Edgar; Kraft Peter; McDermott David H; Abdi Reza^*

来源：Biology of Blood and Marrow Transplantation, 2016, 22(1): 27-36.

DOI：10.1016/j.bbmt.2015.08.037

• Gene polymorphism
• Costimulation
• Hematopoietic stem cell transplantation
• Outcomes
• Infection
• GVHD

Despite stringent procedures to secure the best HLA matching between donors and recipients, life-threatening complications continue to occur after hematopoietic stem cell transplantation (HSCT). Studying single nucleotide polymorphism (SNP) in genes encoding costimulatory molecules could help identify patients at risk for post-HSCT complications. In a stepwise approach we selected SNPs in key costimulatory molecules including CD274, CD40, CD154, CD28, and TNFSF4 and systematically analyzed their association with post-HSCT outcomes. Our discovery cohort analysis of 1157 HLA-A, -B, -C, -DRB1, and -DQB1 matched cases found that patients with donors homozygous for the C variant of rs10912564 in TNFSF4 (48%) had better disease-free survival (P =.029) and overall survival (P =.009) with less treatment-related mortality (P =.006). Our data demonstrate the TNFSF4C variant had a higher affinity for the nuclear transcription factor Myb and increased percentage of TNFSF4-positive B cells after stimulation compared with CT or TT genotypes. However, these associations were not validated in a more recent cohort, potentially because of changes in standard of practice or absence of a true association. Given the discovery cohort, functional data, and importance of TNFSF4 in infection clearance, TNFSF4C may associate with outcomes and warrants future studies.

• 出版日期2016-1
• 单位NIH